Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Tolerability of AllerT in Birch Pollen Allergic Rhinitis
NCT02943720Phase 2Completed
- Sponsor
- Anergis
- Start
- Sep 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of cetirizine in allergic rhinitis (AR), sponsored by Anergis. Started Sep 2016; status: completed.
02
Drugs
cetirizine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02943720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02943720.